NEW YORK (GenomeWeb News) – Orchid Cellmark today reported that its fourth-quarter and fiscal 2008 revenues declined due to lower UK revenues and a decline in revenues from forensic casework and its CODIS business.

Orchid brought in total revenues of $13 million for the three-month period ended Dec. 31, a drop of 13 percent from revenues of $15 million for the fourth quarter of 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.